Biontech Se ADR (BNTX)

$99.85 +1.00 (1.01%)
Market Cap 22.48B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 728,900
Avg Vol 1,151,146
Day's Range N/A - N/A
Shares Out 225.18M
Stochastic %K 78%
Beta 1.40
Analysts Strong Sell
Price Target $139.85

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
OnlyFibs
OnlyFibs Jan. 12 at 2:07 AM
$BNTX is finally pushing the $100 psychological level! 🧬 Options flow is leaning heavily bullish with a 0.24 put-call ratio and whales setting a firm floor at $91. Analysts see 38% upside as the focus shifts to the 2026 oncology pipeline. Reclaim of the 200DMA at $102.58 is the trigger. 📈🚀 #hovdid #BNTX #BioNTech #Biotech #Trading
0 · Reply
taxplanr
taxplanr Jan. 12 at 1:19 AM
Mores success against Lung Cancer with Ivermecton and Fenbendazole $BNTX https://makisw.substack.com/p/ivermectin-and-fenbendazole-testimonial-060?utm_source=post-email-title&publication_id=1385328&post_id=184197672&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Jan. 11 at 12:13 PM
$BNTX $MRNA $PFE efforts to suppress malignantRNA C19 cancer causing link is gaining more attention 🤣🤣🤣 https://www.dailymail.co.uk/sciencetech/article-15440249/cancer-Covid-vaccination-journal-cyberattack.html
0 · Reply
GermanBulle
GermanBulle Jan. 11 at 12:03 PM
$INO Comments & Acting of these real paid bashers reminds me well on the early days of $BNTX. Same heavy bashing before approval. Sold in the 30s and missed the run +450 Dollares. Now looks like same known pattern here. All these damn fukkers who warns in every second is very very suspicious. I will build new positions. I wait for a unexpected news b4 warrants expires. Girl on top could surprise everyone Let’s see I am ready
1 · Reply
taxplanr
taxplanr Jan. 10 at 12:43 AM
Stage 4 breast cancer results using Ivermectin and red light therapy $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThF5pvTM/
1 · Reply
taxplanr
taxplanr Jan. 9 at 4:21 PM
I know you $BNTX investors will be thrilled by this study out of the UAE Egypt and Saudi about how Ivermectin works to kill lung cancer cells $MRNA $PFE It's a race for the Cure https://pubmed.ncbi.nlm.nih.gov/40174264/
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:03 PM
CDC wasn't the only one misleading $BNTX $MRNA $PFE https://justthenews.com/accountability/watchdogs/cdc-misled-public-study-implying-covid-vaccines-save-healthy-kids-ucla?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
0 · Reply
taxplanr
taxplanr Jan. 9 at 2:56 PM
Even advanced stage concers seem to fade against the IFM combo $BNTX $MRNA $PFE https://makisw.substack.com/p/ivermectin-fenbendazole-and-mebendazole-1c8?utm_source=post-email-title&publication_id=1385328&post_id=183929305&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Jan. 9 at 1:29 PM
He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:04 AM
What will $BNTX $MRNA $PFE and friends thin of next? https://anamihalceamdphd.substack.com/p/government-assurances-of-biotech?utm_source=post-email-title&publication_id=956088&post_id=183965336&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
Latest News on BNTX
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

Jan 9, 2026, 10:00 AM EST - 2 days ago

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

Dec 18, 2025, 4:45 AM EST - 24 days ago

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart

Dec 9, 2025, 5:54 PM EST - 4 weeks ago

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

Dec 9, 2025, 7:00 AM EST - 4 weeks ago

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

BMY

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Dec 6, 2025, 3:30 PM EST - 5 weeks ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

Dec 3, 2025, 9:01 AM EST - 5 weeks ago

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

CVAC

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 5 weeks ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

MRNA NVAX PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 5 weeks ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

MRNA NVAX PFE

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 26, 2025, 7:30 AM EST - 6 weeks ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Nov 17, 2025, 6:17 PM EST - 7 weeks ago

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 2 months ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

PFE

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 11:10 AM EST - 2 months ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

PFE

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 2 months ago

BioNTech says collaboration with Pfizer remains unchanged

PFE

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

Nov 3, 2025, 1:44 PM EST - 2 months ago

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:46 PM EST - 2 months ago

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

Nov 3, 2025, 10:29 AM EST - 2 months ago

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

BMY

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:47 AM EST - 2 months ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Nov 3, 2025, 6:45 AM EST - 2 months ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 2 months ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 27, 2025, 7:45 AM EDT - 2 months ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 22, 2025, 6:45 AM EDT - 2 months ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 3 months ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA

BioNTech SE, InstaDeep Ltd - Special Call

Oct 1, 2025, 6:52 PM EDT - 3 months ago

BioNTech SE, InstaDeep Ltd - Special Call

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 23, 2025, 6:45 AM EDT - 3 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 4 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 4 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Sep 8, 2025, 2:01 PM EDT - 4 months ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:05 AM EDT - 4 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 11:00 AM EDT - 4 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Pfizer, partner BioNTech say updated COVID shot shows better immune response

Sep 8, 2025, 7:02 AM EDT - 4 months ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Sep 8, 2025, 6:45 AM EDT - 4 months ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

BioNTech, Duality score initial trial win with breast cancer precision drug

Sep 5, 2025, 5:13 AM EDT - 4 months ago

BioNTech, Duality score initial trial win with breast cancer precision drug

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 4 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Aug 27, 2025, 12:50 PM EDT - 4 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7, 2025, 9:00 PM EDT - 5 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 5, 2025, 1:36 PM EDT - 5 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 5 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 10:32 AM EDT - 5 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 5 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 5 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 4, 2025, 6:45 AM EDT - 5 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Aug 1, 2025, 4:51 PM EDT - 5 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 5 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 5 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Aug 1, 2025, 5:59 AM EDT - 5 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Pandemic darlings Moderna, BioNTech are now on two different paths

Jul 31, 2025, 7:00 AM EDT - 5 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 6 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 6 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

Jul 23, 2025, 4:11 AM EDT - 6 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 21, 2025, 6:45 AM EDT - 6 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

OnlyFibs
OnlyFibs Jan. 12 at 2:07 AM
$BNTX is finally pushing the $100 psychological level! 🧬 Options flow is leaning heavily bullish with a 0.24 put-call ratio and whales setting a firm floor at $91. Analysts see 38% upside as the focus shifts to the 2026 oncology pipeline. Reclaim of the 200DMA at $102.58 is the trigger. 📈🚀 #hovdid #BNTX #BioNTech #Biotech #Trading
0 · Reply
taxplanr
taxplanr Jan. 12 at 1:19 AM
Mores success against Lung Cancer with Ivermecton and Fenbendazole $BNTX https://makisw.substack.com/p/ivermectin-and-fenbendazole-testimonial-060?utm_source=post-email-title&publication_id=1385328&post_id=184197672&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Jan. 11 at 12:13 PM
$BNTX $MRNA $PFE efforts to suppress malignantRNA C19 cancer causing link is gaining more attention 🤣🤣🤣 https://www.dailymail.co.uk/sciencetech/article-15440249/cancer-Covid-vaccination-journal-cyberattack.html
0 · Reply
GermanBulle
GermanBulle Jan. 11 at 12:03 PM
$INO Comments & Acting of these real paid bashers reminds me well on the early days of $BNTX. Same heavy bashing before approval. Sold in the 30s and missed the run +450 Dollares. Now looks like same known pattern here. All these damn fukkers who warns in every second is very very suspicious. I will build new positions. I wait for a unexpected news b4 warrants expires. Girl on top could surprise everyone Let’s see I am ready
1 · Reply
taxplanr
taxplanr Jan. 10 at 12:43 AM
Stage 4 breast cancer results using Ivermectin and red light therapy $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThF5pvTM/
1 · Reply
taxplanr
taxplanr Jan. 9 at 4:21 PM
I know you $BNTX investors will be thrilled by this study out of the UAE Egypt and Saudi about how Ivermectin works to kill lung cancer cells $MRNA $PFE It's a race for the Cure https://pubmed.ncbi.nlm.nih.gov/40174264/
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:03 PM
CDC wasn't the only one misleading $BNTX $MRNA $PFE https://justthenews.com/accountability/watchdogs/cdc-misled-public-study-implying-covid-vaccines-save-healthy-kids-ucla?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
0 · Reply
taxplanr
taxplanr Jan. 9 at 2:56 PM
Even advanced stage concers seem to fade against the IFM combo $BNTX $MRNA $PFE https://makisw.substack.com/p/ivermectin-fenbendazole-and-mebendazole-1c8?utm_source=post-email-title&publication_id=1385328&post_id=183929305&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Jan. 9 at 1:29 PM
He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:04 AM
What will $BNTX $MRNA $PFE and friends thin of next? https://anamihalceamdphd.substack.com/p/government-assurances-of-biotech?utm_source=post-email-title&publication_id=956088&post_id=183965336&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Jan. 8 at 5:20 PM
$PFE $BNTX has known about DNA contamination of the C19 jabs for at least 2 years https://www.instagram.com/reel/DTO5wf1iBxG/?igsh=MWhwd2Q2MjJqejBkaA==
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 8 at 4:24 PM
🧬 $PDSB Advancing Immunotherapy in Cancer & Infectious Disease 🧪 PDS Biotechnology is a immunotherapy company developing targeted treatments for cancer and infectious diseases using its proprietary Versamune and Infectimune platforms. 👉🏽 Phase 3 lead asset: Versamune HPV for HPV16-positive head & neck cancer 👉🏽 Proven immune activation: Strong T-cell responses and durable survival 👉🏽 Focused strategy: Clear oncology lead with combination potential 👉🏽 Execution-driven: Capital aligned to complete Phase 3 development Their unique technology: 🔬 Versamune: Programs tumor-specific killer T cells 🔬 Infectimune: Applies immune programming beyond oncology Supported by leading academic and NCI-backed institutions, PDS Biotechnology is progressing a Phase 3 oncology program with significant upside potential. Communicated Disclaimer: https://stockresearchtoday.com/revolutionizing-biotech-for-cancer-treatment/ Sector Peers: $PFE $AMGN $MRK $BNTX
0 · Reply
htw7448
htw7448 Jan. 7 at 8:36 PM
$BNTX will grow to the biggest oncology giant within next 6-8 years. A lot of upside potential.
0 · Reply
Pillemann1
Pillemann1 Jan. 7 at 8:11 PM
$BNTX ??
0 · Reply
taxplanr
taxplanr Jan. 7 at 3:36 PM
Did you all see this China study on Fenbendazole on Anti-Tumor effects against cervical cancer? $BNTX $MRNA $PFE https://pubmed.ncbi.nlm.nih.gov/40509264/
0 · Reply
taxplanr
taxplanr Jan. 7 at 3:28 PM
Ivermectin Fenbendazole and CLO2 killing cancer $BNTX $MRNA $PFE https://makisw.substack.com/p/ivermectin-fenbendazole-and-chlorine?utm_source=post-email-title&publication_id=1385328&post_id=183774487&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
tkstockpicker
tkstockpicker Jan. 7 at 3:26 PM
$BNTX added
0 · Reply
taxplanr
taxplanr Jan. 7 at 2:47 PM
$BAYRY suing malignantRNA makers $BNTX $MRNA $PFE over misusing it's mRNA patent Gates companies lawfaring against Gates companies 🤣 https://www.reuters.com/legal/litigation/bayer-sues-covid-vaccine-makers-over-mrna-technology-2026-01-06/
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 7 at 1:41 PM
$PFE $BNTX $MRNA Bayer sues COVID vaccine makers over mRNA technology - Reuters https://ooc.bz/l/88868
1 · Reply
htw7448
htw7448 Jan. 6 at 4:07 PM
$BNTX : are there any links for data readout available?
0 · Reply
taxplanr
taxplanr Jan. 6 at 2:57 PM
$BNTX $MRNA $PFE the whole world is learing 🤣 how to cure cancer https://makisw.substack.com/p/mebendazole-in-ovarian-cancer-how?utm_source=post-email-title&publication_id=1385328&post_id=183659427&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
2 · Reply
StockAnalyst_SA
StockAnalyst_SA Jan. 6 at 2:51 PM
🟢 $ZETA | DA Davidson Buy PT $29 Full analysis here! It's free👉 @StockAnalyst_SA (No noise !!) 📈 Stock Move After-hours +8% (up ~9% intraday) Driven by strategic collaboration with OpenAI 🤖 Partnership Highlights Integrating OpenAI models + ZETA Athena Two new agentic apps: Insights & Advisor Athena GA by end of 1Q26 (was 1H26) 💡 Takeaway Reiterate BUY / PT $29 Valuation: 30x 2026 FCF Tech + strategic collaboration → long-term growth potential $BNTX $LH $PPG $CG
0 · Reply